Skip to main content

Matt Riley

Head of Investor Relations

PAVmed Inc. (PAVM)

Equibles does not estimate personal net worth.

Get an email with a short summary when PAVmed Inc. publishes a filing, an earnings call transcript or a press release.

Get PAVM alerts

About Matt Riley

Matt Riley is recorded as Head of Investor Relations at PAVmed Inc. (PAVM). Matt Riley has spoken on 6 earnings calls across 1 company, most recently for PAVmed Inc. on August 14, 2026. PAVmed Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at PAVmed Inc. includes Lishan Aklog (CEO), Michael J. Glennon (Chairman and Board Member), Dennis McGrath (CFO) and 7 others.

Matt Riley on recent calls

“Joining me today on the call are Dr. Alicia Aklok, Chairman and Chief Executive Officer of PADMED, along with Dennis McGrath, Chief Financial Officer. The press release announcing our business update and financial results is available on PADMED's website.”
Head of Investor Relations, PAVmed Inc. Q2 FY2026 Earnings Call ·
“Joining me today on the call are Dr. Lishan Eklag, Chairman and Chief Executive Officer of PathMed, along with Dennis McGrath, Chief Financial Officer of PathMed.”
Head of Investor Relations, PAVmed Inc. Q1 FY2026 Earnings Call ·
“Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer of PAVmed, along with Dennis McGrath, Chief Financial Officer of PAVmed.”
Head of Investor Relations, PAVmed Inc. Q3 FY2025 Earnings Call ·
“Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer of PAVmed, along with Dennis McGrath, Chief Financial Officer of PAVmed.”
Head of Investor Relations, PAVmed Inc. Q3 FY2024 Earnings Call ·
“Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer of PAVmed, along with Dennis McGrath, Chief Financial Officer of PAVmed.”
Head of Investor Relations, PAVmed Inc. Q2 FY2024 Earnings Call ·

Affiliation history

Company network

Leadership on record at PAVmed Inc.

Recent activity